Diagnosis of Bovine Genital Campylobacteriosis in South America
- 1Instituto Nacional de Investigación Agropecuaria (INIA), Plataforma de Salud Animal, Estación Experimental INIA La Estanzuela, Colonia, Uruguay
- 2Veterinary Population Medicine Department, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN, United States
Bovine genital campylobacteriosis (BGC) is a venereal infectious disease that affects reproduction. It is caused by the Gram-negative bacillus Campylobacter fetus subspecies venerealis (Cfv), which may include the biotype intermedius. The bull is a lifelong asymptomatic carrier and transmitter of the disease. In females Cfv may cause infertility and sporadic abortion. The objective of this study is to review and discuss methods for the diagnosis of BGC, its prevalence and economic impact in South America. BGC is a worldwide distributed disease and can cause a pregnancy rate decrease of 15–25%. The farm prevalence of BGC in different regions of South American countries shows a variation between 2.3 and 100%. Discrepancies may depend on the differences on sanitary, management, and reproductive practices between farms and regions, but also on the interpretation of different diagnostic tests. Currently known laboratory tests include bacterial culture, direct immunofluorescence, immunoenzymatic assays, vaginal mucus agglutination test, PCR-based methods, histology and immunohistochemistry, which are applied and interpreted in diagnostic laboratories at different scales. Epidemiologic data of BGC in South America should be interpreted with caution. High prevalence has been reported in some studies, although the low specificity of the diagnostic tests used could lead to an overestimation of the results.
Reproductive diseases of cattle resulting in infertility and abortion cause significant economic losses (1). On average, a specific cause can only be identified in ~45% of the aborted bovine fetuses examined in veterinary diagnostic laboratories in South America. The proportion of abortion cases attributed to Campylobacter spp. ranges from 0 to 13% of all fetuses with a confirmed etiology (2–6). Similar values are found in other countries, such as the USA, where a confirmed diagnosis is reached in 35.25% of the cases, and Campylobacter spp. accounts for 1.8–10.6% of the cases with an etiologic diagnosis (7). Venereal diseases, such as bovine genital campylobacterosis (BGC) caused by Campylobacter fetus subspecies venerealis (Cfv) (8), are important causes of these reproductive losses. Campylobacter fetus is a curved, motile, non-spore forming, Gram-negative bacillus with one or two polar flagella. The species comprises the subspecies Cfv, which may include the biotype intermedius (9, 10), and the subspecies Campylobacter fetus fetus (Cff) and C. fetus testudinum (Cft) (11). Campylobacter fetus fetus is a common resident of the mammalian intestine and can cause abortion in cattle and sheep (12), as well as enteric or systemic disease in humans (13). Transmission of Cff occurs mainly via the fecal-oral route; this is followed by a transient bacteremia during which, in pregnant ruminants, the agent can translocate to the placenta resulting in placentitis and abortion (14). Cft is not clinically important for cattle, it infects in reptiles and has also been isolated from humans (11).
Bovine genital campylobacteriosis was first recognized as a cause of infertility in cattle in the 1940s and was known to have worldwide distribution in the 1960s (15). In South America it was first diagnosed in 1955 in Brazil, through the isolation of the bacterium from an aborted bovine fetus (16). Bovine genital campylobacteriosis is an important cause of reproductive failure, infertility and irregular estrus in both heifers and cows, although heifers are more susceptible to infection due to the low levels of immunity (17–19).
Herds with Cfv infection often have reduced breeding efficiency, including pregnancy rates lower than expected, embryonic losses, sporadic abortions, increased number of services per conception, extended calving season, and a longer interval between calving. Abortions are more commonly detected between the 4th and 6th months of gestation (15, 20–23). The average pregnancy rate in infected herds varies depending on the relative proportion of carriers, susceptible and immune breeding-age females, and infected and non-infected bulls (21, 24).
Bulls are the most important reservoirs and disseminate the disease through coitus (9). Campylobacter fetus venerealis lodges in the preputial crypts; the hosts do not develop any clinical signs or lesions due to this infection, acting as asymptomatic carriers. Infection does not affect libido or sperm quality (9, 20). For this reason, bulls should be the target category for diagnostic approaches, epidemiological studies, as well as control and prevention strategies. After venereal transmission in females, infertility associated with Cfv infection occurs due to endometritis that causes changes in the uterine environment that interfere with embryo nesting. In addition, the inhospitable environment can also affect embryos that are already implanted and fetuses (25).
Dairy and beef production play an important role in the economy of South American countries. Brazil, Argentina, and Uruguay are the three countries with highest cattle stock in the region, reaching 172, 57, and 13 million heads in 2016, respectively (26–28). The awareness of the socioeconomic importance of this sector, and the economic impact of venereal diseases of cattle (BGC and trichomonosis), led in 2006 to the implementation of the Provincial Control and Eradication Program (PCEP) of bovine venereal diseases by the Ministry of Production of the province of La Pampa, Argentina, together with the College of Veterinarians, the National Institute of Agricultural Technology (INTA) and the National Service of Sanitation and Agri-food Health and Quality (SENASA). Engagement in the program is mandatory for all herds in La Pampa, testing should be performed prior to cattle movements. All non-virgin bulls are tested twice a year, and positive bulls are culled within 120 days of diagnosis (testing and culling strategy). The PCEP proved effective to reduce the prevalence of these diseases from 2007 to 2014 in the province (29), providing a framework to set up sampling procedures and testing methodologies to identify infected bulls more efficiently. However, there are intrinsic difficulties with the laboratory diagnosis of BGC in the region that have yet to be overcome to establish more effective control strategies (30).
The diagnosis of BGC presents significant challenges. The objective of this study is to review and discuss methods for the diagnosis of BGC, and its prevalence and economic impact in South America.
Diagnosis OF BGC
For the diagnosis of BGC, various methods that demonstrate either the presence of Cfv (i.e., bacterial culture) or some of its components (i.e., DNA, proteins), or host-developed immune response against Cfv (immunologic assays) have been developed (8) (Table 1). The quality of the samples submitted for diagnostic testing is extremely important because it directly influences the accuracy of the results obtained (31).
Because bulls are lifelong asymptomatic carriers, and disseminators of the disease, they are the animals of choice for the diagnosis of BGC in endemic herds (21). Cfv establishes persistent colonization of the preputial crypts, which may be linked to the modification of the molecular composition of bacterial surface antigens that allow it to escape the local immune response (32). Given the ecologic niche of Cfv, diagnostic samples for detecting or isolating the agent should preferably be taken from the prepuce of bulls.
For this purpose, smegma may be obtained from the preputial and penile mucosa by three different methods: (A) scraping: performed by scarifying the foreskin and penile mucosa using a disposable plastic or sterilizable reusable metal scraper (33) that is then rinsed in phosphate buffered saline (PBS); (B) aspiration: performed through a disposable plastic sheath coupled to the artificial insemination pipette to suction the smegma; and (C) washing: performed by introducing about 20–30 mL of PBS into the foreskin, massaging it with the closed ostium before collecting the material through a siphon system (8, 34). Preputial scraping, compared to the other two methods, is the technique of choice because more C. fetus-positive samples are identified when samples are obtained by this method (33). McMillen et al. (35) confirmed that the scraping method is more effective in recovering Cfv than the other two collection methods. In addition, the authors emphasize that this technique is easier and safer to perform.
Bulls should be kept in sexual rest for 15 days before sampling, and three sample collections, with the same resting interval, should be performed to increase the diagnostic sensitivity (34). Downsides of this practice include that A-the bulls need to be out of service for ~45 days, and B-multiple visits to the farms are required to complete sampling, which implies greater logistic efforts by both veterinarians and farmers.
In contrast, cows and heifers infected with Cfv are temporally colonized by this pathogen, thus females are not usually sampled and tested for herd screening purposes. However, when gestational losses occur, the cervicovaginal mucus and placenta from aborted dams, and fetal organs and fluids represent adequate diagnostic samples (3, 21). The same plastic sheaths coupled to the artificial insemination pipette used in bulls, can be successfully used in dams to suction cervicovaginal mucus. This represents an easy and practical sampling method. Eventually, a sterile speculum can be used to collect a cervicovaginal washing (8, 34, 36).
Current BGC diagnostic methods include: A-tests that either demonstrate the presence of Cfv (i.e., bacterial culture) or its components (i.e., direct immunofluorescence or immunohistochemistry for the detection of surface proteins, PCR-based methods for detection of DNA), or B-tests that aim at detecting host-developed immune response against Cfv (i.e., immunoenzymatic assays, vaginal mucus agglutination test) (3, 8, 22, 31, 37–41).
Bacterial Culture Approaches
Genital secretions (preputial smegma and cervicovaginal mucus), placenta and fetal fluids (i.e., abomasal content) and/or tissues (i.e., liver and lung) represent adequate samples for isolation and further identification of Cfv. In cases where BGC is suspected, samples should be collected aseptically and transported to the diagnostic laboratory (8, 34). To increase the chances to isolate this fastidious microorganism, cultures should be carried out within 4 h of sample collection (42). However, the use of proper transport media extends this period to about 24 h (42). Transport and enrichment media (TEM) are available to optimize culture, such as Weybridge, Cary-Blair, Clark, Thomann, Lander, and 0.85% sterile saline solution (8, 43–45). Usually, Weybridge TEM is the medium of choice, as it is efficient in maintaining viable Cfv and reducing contamination (44). Thomann TEM has proved effective for both culture and PCR approaches (45).
Physiological characteristics of Cfv makes laboratory culture difficult as this microaerophilic and fastidious microorganism requires special growth conditions. Procedures for isolating Cfv involve the use of enriched culture media with antibiotics to minimize the growth of contaminants, and incubation in microaerobic conditions (5–10% O2, 5–10% CO2, preferably 5–9% H2, and the rest of N2), at 37°C for a minimum of 48 h (8, 34).
Enriched culture media such as Skirrow agar, bright green agar, and blood agar are recommended for Cfv isolation. When managing microbiologically complex clinical samples, such as preputial smegma, Skirrow agar is the best choice (44). This medium contains inhibitors that minimize the growth of undesirable contaminating microorganisms, thus facilitating the development of Cfv and the consequent observation of compatible bacterial colonies (44). Passive filtration of the sample onto the media can increase the recovery of Cfv and reduce fungal contamination (42). Additionally, Skirrow could also be used for the isolation of Brucella spp., pathogens that share niche and are present in South America (46).
The morphologic characterization of the bacterial colonies is not sufficient for the identification of Campylobacter to the species and subspecies levels. For this reason, it should be considered that Cff, which is also clinically important but not related to BGC, can grow in the same selective media and show similar colony characteristics as Cfv. These subspecies should be distinguished by their phenotypic characteristics based on biochemical tests (8, 21) or molecular approaches (see section on PCR-based methods below). While Cff produces H2S and is able to grow in the presence of 1% glycine and 0.1% sodium selenite, Cfv does not (8, 12). However, there is concern about the reliability of these biochemical characteristics for definite subspecies identification, as some Cfv strains had acquired the glycine tolerance characteristic. Chang and Ogg (47) described that this process occurred by transduction and mutation events. In addition, a group of Cfv denominated biovar intermedius also, as Cff, produces H2S, which may lead to reaching erroneous conclusions regarding the identification of Cfv (10, 12).
Direct Immunofluorescence (DIF)
Direct immunofluorescence is widely used for the diagnosis of BGC on samples of preputial smegma, cervicovaginal mucus, uterine tissue, placenta, and abomasal fluid, lung and liver from aborted fetuses (3, 22, 31, 36, 41, 48, 49), and is listed by the OIE as a prescribed diagnostic method for international bull trade (8). This test proves to be very effective even in contaminated field samples. The detection limit is 104 and 102 Cfv CFU/mL in non-centrifuged and centrifuged preputial washings, respectively (31).
For DIF, samples should be stored in PBS with 1% formalin after collection. Genital fluid samples should be centrifuged to remove debris and contaminating particles. The fluid is placed on glass slides and subsequently fluorescein isothiocyanate conjugated (FITC) antiserum is added in the appropriate dilution. The slides are examined under ultraviolet light in a fluorescence microscope. Samples showing fluorescent bacteria with the typical C. fetus morphology are considered positive (8, 31).
A study performed in Argentina evaluating preputial smegma and cervicovaginal mucus through DIF determined a sensitivity and specificity of 69.4 and 94.4%, respectively (36). A similar study in Brazil estimated a sensitivity of 92.59% and a specificity of 88.89% (31). The adequate interpretation of the slides may be challenging, especially when there are contaminating particles and cellular debris with low concentration of Cfv in the fields of microscopic observation (31, 41). The performance of this technique is directly influenced by the quality of the sample and the microscope used, and also by the observer's experience (50), which can lead to a reduction in test sensitivity. Therefore, adequate training is key in diagnostic settings. Contrary to this statement some authors consider that the effect of experienced observers on test performance is minimal (31).
Routine DIF protocols generally employ polyclonal rabbit raised FITC antibodies that do not discriminate between the two C. fetus subspecies (8). There is a risk for false positive Cfv results when the sample contains Cff (8, 31), therefore caution should be taken when interpreting DIF results alone. Chicken raised antibodies (IgY) against C. fetus can also be employed in DIF protocols. Although IgY based protocols had similar sensitivity when compared with rabbit IgG they show lower unspecific background fluorescence and are cheaper to produce (48).
However, DIF is rapid and advantageous compared to more time-consuming assays for C. fetus testing. Using samples of vaginal mucus, Marcellino et al. (41) compared the diagnostic efficiency of the DIF technique with the bacteriological culture, obtaining a moderate agreement (kappa coefficient = 0.52) between these techniques. However, usually vaginal mucus samples do not harbor as many microbial contaminants as preputial samples. Considering that Cff and Cfv are both subspecies of clinical importance and may both cause reproductive losses, DIF is an easily applied technique suitable for the screening of C. fetus in endemic BGC herds and abortion episodes. However, for the definitive diagnosis of BGC, more specific and sensitive tests are needed to provide evidence of Cfv infection.
Currently, DIF is widely used in most diagnostic laboratories in South America as the only diagnostic test for BGC, possibly because cultivation is a difficult technique to use for routine testing, and PCR protocols are not yet standardized and validated under South American conditions. The lack of experience, equipment and funding required to conduct more sensitive and/or specific tests is still a limiting factor in most veterinary diagnostic laboratories in the region.
ELISA and Other Immunologic Assays
An enzyme-linked immunosorbent assay (ELISA) was developed to detect secretory IgA antibodies specific for Cfv antigen in the vaginal mucus and used in the diagnosis of Cfv induced abortion (51). In infected cows, especially those that aborted recently, there is a strong immune response of local antibodies in the vaginal and uterine mucosa (51). This test has been used to screen for BGC in cattle herds with infertility and abortions; the specificity was found to be 98.5%, although sensitivity could not be estimated (43). It has been postulated that vaccination against campylobacteriosis does not interfere with the IgA ELISA test, as only IgG, but not IgA, is secreted in the vaginal mucus of vaccinated cows (43). As the immune response in the preputial mucosa of bulls carrying the bacterium is fleeting (32), tests aiming at detecting antibodies in preputial smegma should be avoided.
ELISA tests have also been developed for the detection of C. fetus antigens in enriched bacterial cultures. In a study, field samples including preputial washings, placenta from aborted cows, and abomasal fluid from aborted fetuses, were incubated for 4 days in Clark's TEM and then tested with a monoclonal antibody-based antigen capture ELISA for the detection of C. fetus as a screening test. The sensitivity and specificity were of 100 and 99.5%, respectively, compared to conventional culture (52).
An indirect ELISA for the detection of serum antibodies against C. fetus was developed with rSapA-N, a recombinant protein codified by the C. fetus-specific virulence gene sapA. The specificity and sensitivity of this method were 94.3 and 88.6%, respectively (53). This test does not discriminate between antibodies against the two C. fetus subspecies.
ELISAs can be used as a first screening of herds with C. fetus infection, allowing for rapid large-scale sample processing (43, 52–54). However, there are no reports of the application of these techniques for BGC diagnosis in South American countries, and commercial kits are not readily available in this region.
The vaginal mucus agglutination test (VMAT), was used in the past decades to detect antibodies in vaginal mucus washes. The sensitivity was ~50% (15, 55). This assay resulted in many false negative results not only because of the intrinsic low sensitivity, but also because antibodies are detected in vaginal mucus after 2 and before 7 months of infection (56). Therefore, the use of VMAT was discouraged. This test has not been widely used with diagnostic purposes in South America.
Culture-independent methods such as polymerase chain reaction (PCR) (10), real time PCR (35, 39, 57) and multiplex PCR (37–39, 58) are also used for the diagnosis of BGC. These approaches have improved reported sensitivity and specificity compared to other techniques such as microbiological culture (57). These techniques can detect specific Campylobacter DNA sequences by means of the design of specific primers (37, 39, 59).
The differentiation of Cfv from other species and subspecies can be carried out through the molecular genotype classification by means of multiplex PCR techniques. In these approaches, specific primers designed to detect Campylobacter spp. or the different subspecies are used (37, 38). Another sensitive variation is real time PCR that is theoretically capable of detecting and quantifying DNA from a single Cfv cell in field samples (35, 57, 59). PCR-based methods have advantages over microbiological cultures, such as simplicity in interpretation of results. A multiplex PCR protocol targeting sequences present in Cfv but not in Cff, was developed in Uruguay (39). Interestingly, genomic DNA is directly extracted from the abomasal fluid of aborted bovine fetuses and the downstream process involves only one step (39). Applying this protocol, Cfv biovar intermedius could be detected when cultures and biochemical tests were not consistent (39, 60, 61). However, a recent study demonstrates that the virB11 gene, used as a target gene for differentiation between subspecies in the above-mentioned PCR protocol (39), is not exclusively present in Cfv strains and is not always absent in Cff strains (62).
The complete genome of an Argentinian Cfv biovar intermedius strain was sequenced (61). The genomic information of such atypical strains would optimize the development of tools for more specific molecular diagnosis. Recently, the study of two genomes, reported incongruities between the Cff and Cfv lineages and the biochemical characteristics used for their differentiation, questioning the clinical relevance of subtyping mammalian strains (63, 64).
Van der Graaf-van Bloois et al. (60) tested five PCRs that are routinely used by diagnostic laboratories, and surprisingly none of them were able to correctly identify strains of C. fetus at the subspecies level. All the tests were compared with the methods of amplified fragment length polymorphism (AFLP) (65) and multilocus sequence typing (MLST) (10), which so far are the only techniques that have proven to reliably differentiate the two subspecies. Unfortunately, these assays are cumbersome, costly and impractical for routine use.
The differentiation of C. fetus subspecies is essential for the implementation of efficient Cfv control and eradication programs, and for investigating the public health burden of C. fetus subspecies, however its genomic evolution in mammals remains poorly understood. A recent study provides the phylogenetic and evolutionary structure of C. fetus which could guide the development of methods for differentiation and epidemiological surveillance of bovine and human strains (66).
In South America, even though molecular tests have been developed and used in recent years, their applicability to routine laboratory diagnosis is currently subject to discussion. This is due to the discrepancy between results obtained by different protocols, and because most protocols cannot be performed with confidence directly on DNA extracted from field samples (i.e., preputial smegma). These factors have led so far to the non-acceptability of the technique by field veterinarians and diagnostic laboratories. Even though it is likely that these technologies will be increasingly adapted by veterinary laboratories in years to come, particularly considering that they are accepted by the OIE standards (8). Phenotypic tests are still the only ones that are reliable and available in South America for the identification of subspecies. However, they are poorly reproducible and do not correspond to the genomic characteristics of some strains (63, 64). Due to these aspects, further research is needed to validate molecular techniques with locally isolated strains and to assess their applicability in the region.
Histochemical and Immunohistochemical Methods
Histology and immunohistochemistry are useful and effective diagnostic methods in natural cases of bovine abortions by C. fetus (22), particularly in fetuses and placentas from which C. fetus cannot be successfully isolated because of poor preservation of the samples (i.e., aborted fetuses that are autolytic, frozen or deteriorated upon arrival to the laboratory) (23).
The main histologic lesions in aborted fetuses are suppurative pneumonia, myocarditis, fibrinous serositis, interstitial nephritis, hepatitis, gastroenteritis, meningitis, and necrotizing placentitis; however, these lesions are not pathognomonic of C. fetus infection (22, 23, 40). Immunohistochemistry for the detection of C. fetus antigens in formalin-fixed paraffin-embedded tissues, in the absence of bacterial isolation and molecular evidence of infection, is an alternative and practical method to establish the diagnosis in aborted fetuses (22, 23, 36).
Pathological examination coupled with DIF and/or bacterial culture has been widely used in Brazil, Argentina, and Uruguay for the diagnosis of Campylobacter-induced abortion (3–6, 22, 23, 67). However, this does not seem to be a broadly used diagnostic approach in other countries in the region.
Economic Impact and Prevalence
Bovine genital campylobacteriosis is a disease of worldwide distribution (24). The prevalence is high in developing countries where extensive cattle breeding is widely practiced (21), and the infection status in a herd can be easily overlooked. Bovine genital campylobacteriosis may lead to significant economic losses in countries that maintain reproductive management based on natural mating with bulls, such as Uruguay, Brazil, Argentina and Colombia (68–70).
Studies on beef herds show that the disease can lead to a 15 to 25% reduction in pregnancy rates (2). In dairy herds, C. fetus infection negatively influenced milk production (71), however, these losses were not quantified. Considering that the cost of an abortion in dairy cattle in the Unites States has been estimated in approximately $555 per animal (72), a hypothetical reduction of 20% for gestational losses in a herd of 1,000 pregnant cows would represent an economic loss of $111,000.
There is no literature available on the quantification of economic losses caused by BGC in South America. In the last decades high prevalence of BGC has been reported in dairy and beef herds in Brazil (20, 73–79), Uruguay (49), Argentina (29, 36, 80), and Colombia (81). A summary of studies reporting prevalence of BGC in different regions of South American countries between 1984 and 2018 is presented in Table 2. It should be mentioned that most of the studies were conducted with few herds, so it is likely that they do not reflect the true prevalence accurately, as highlighted by Molina et al. (29).
Table 2. Studies reporting prevalence of BGC in different regions of South American countries between 1984 and 2018.
The herd-level prevalence of BGC in different regions of the studied countries ranged between 2.3 and 100%. This dispersion is expected since the transmission of the disease depends on the sanitary and reproductive management practices used at each site (82). However, it is important to note that in many of these studies the differences could be associated with the diagnostic tests used. Most of the studies were based on DIF (Table 2) which does not distinguish the subspecies of C. fetus (31). Direct immunofluorescence should not be used as the unique diagnostic technique for confirmation of Cfv infection.
In Uruguay, a national study in beef cattle evaluated 1,754 samples of preputial smegma and determined a prevalence of 28% of positive bulls in 142 of 230 (37%) farms. The diagnosis was performed by DIF and bacterial culture directly from preputial smegma samples enriched in TEM for 72 h. In 47 of the farms the isolation of C. fetus was successful and 35 (75%) of these isolates were identified as Cfv (49). Culture and identification of Cfv reliably confirmed BGC in 15.2% of the farms, suggesting that the prevalence of 37% was likely overestimated. These variations may have occurred due to the differences between sensitivity and specificity inherent to the diagnostic tests used in different studies.
Several studies have also been carried out in different regions of Brazil, diagnosing BGC by DIF in up to 51.7% of the animals evaluated (20, 73–76). Rocha et al. (75) determined that the prevalence in bulls, by means of DIF, was 35.9%; however, it drop to 10.3% when using bacterial culture.
More recent works performed using PCR techniques that are more specific and sensitive than DIF and can differentiate between subspecies of C. fetus determined a lower prevalence of 7.7% (79) and 1.8% (78), in different regions of Brazil. Additionally, Filho et al. (79) confirmed the findings through whole genome sequencing of the strains.
Direct immunofluorescence can be used as a screening test for C. fetus (20, 49, 73–75, 80). However, DIF should not be used for the definitive diagnosis of Cfv infection. PCR-based methods and bacterial culture presented better results to estimate the prevalence of BGC (79, 81). However, a critical evaluation of clinical relevance is necessary when the diagnosis of BGC is established by phenotypic (63) and genotypic tests alone (83). On & Harrington (84) argue that the combination of identification methods (phenotype and PCR) mostly supports the taxonomic division of the species; however, the use of more than one method is necessary because the precise identification between subspecies is still problematic.
While reliable diagnostic tests for Cfv and Cff detection are not validated in South America and the real prevalence is not reported, recommending adequate control strategies is a difficult task (29). At this point, although DIF or PCR techniques can be used, they could be used as screening to detect C. fetus without disregarding isolation and identification. Isolation, in addition to still being essential for diagnosis, is also fundamental to identify the circulating strains and perform molecular studies, besides determining the possible role of Cff strains in the production of venereal disease.
Bovine genital Campylobacteriosis is known to cause reproductive losses in various South American countries, however, these losses have not been quantified. The lack of widespread availability of simple, sensitive, and specific techniques for the laboratory diagnosis of Cfv infection, combined with limited laboratory infrastructure, insufficient resources for the development, and/or improvement of diagnostic tests, are key limiting factors for the diagnosis and control of BGC in the region.
Broader epidemiological studies to determine prevalence, risk factors and consequently estimate the economic losses of BGC in South America should be conducted. Because bulls are lifelong carriers of Cfv in the prepuce, they should be the sampling targets in BGC endemic herds and tested for Cfv with reliable screening and confirmatory diagnostic tests.
The combination of evidence increases the effectiveness of the results when correctly interpreted. Direct immunofluorescence and antigen capture ELISA determine the presence of C. fetus, being valuable for screening, but should be used in conjunction with bacterial isolation and phenotypic identification. PCR and/or DNA sequencing are valuable tools for confirming phenotypic tests. The isolation of Cfv is crucial to obtain autochthonous strains for future research and to develop and validate diagnostic techniques and reduce the cost of diagnosis. PCR-based methods appear to be promising for the diagnosis in field samples of preputial smegma, vaginal mucus, and tissues and/or fluids from aborted fetuses and/or placentas, as well as bacterial isolates. The use of these techniques for the unequivocal identification of Cfv and therefore the final diagnosis of BGC is recommended because they are more specific and sensitive and can differentiate between C. fetus subspecies. Veterinary diagnostic laboratories in South America should work toward accreditation and validation of diagnostic tests to provide reliable diagnostics to veterinary practitioners and farmers aiming at controlling or eradicating BGC from endemic herds and preventing the introduction of infected bulls in disease-free herds.
Although endemic, there are still no official guidelines regarding BGC control in South American herds. The development of regional health policies with monitoring and surveillance would help to establish control and eradication programs.
CS: first author who was responsible for the search of the works, organization and writing of this manuscript; MF: contribution in the revision of the manuscript, especially in what concerns molecular biology and language; FG: contribution in the revision of the manuscript and language; MM-R: contribution in the revision of the manuscript and language; FR-C: Last author and coordinator, his contribution was essential for the completion of this work, applied his corrections and critical reviews in the theoretical part and in the language. All authors have seen and approved the content of the manuscript and have contributed significantly to the work.
The research that originated the results presented in this publication received funds from the Uruguayan Agencia Nacional de Investigación e Innovación (ANII) by grants FSSA_X_2014_1_105696 and POS_FSSA_2015_1_1005321.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors thank Dr. Carlos Campero for the critical review of this manuscript.
5. Fernandez ME, Campero CM, Morrell E, Cantón GJ, Moore DP, Cano A, et al. Pérdidas reproductivas en bovinos causadas por abortos, muertes prematuras, natimortos y neonatos: casuística del período 2006–2007. Rev Med Vet. (2007) 88:246–54.
6. Antoniassi NAB, Juffo GD, Santos ASD, Pescador CA, Corbellini LG, Driemeier D. Causes of bovine abortion diagnosed by the Sector de Veterinary Pathology of the Federal University of Rio Grande do Sul in the years 2003–2011. Pesq Vet Bras. (2013) 33:155–60. doi: 10.1590/S0100-736X2013000200004
8. OIE. Bovine Genital Campylobacteriosis (Chap. 2.4.4) (2017). Available online at: http://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/2.04.04_BGC.pdf (Accessed June 24, 2018).
9. Eaglesome MD, Garcia MM. Microbial agents associated with bovine genital tract infections and semen. Part 1. Brucella abortus, Leptospira, Campylobacter fetus and Tritrichomonas foetus. Vet Bull. (1992) 62:743–75.
10. Van Bergen MA, Dingle KE, Maiden MC, Newell DG, van der Graaf-Van Bloois L, van Putten JP, et al. Clonal nature of Campylobacter fetus as defined by multilocus sequence typing. J Clin Microbiol Infect. (2005) 43:5888–98. doi: 10.1128/JCM.43.12.5888-5898.2005
11. Fitzgerald C, Tu ZC, Patrick M, Stiles T, Lawson AJ, Santovenia M, et al. Campylobacter fetus subsp. testudinum subsp. nov., isolated from humans and reptiles. Int J Syst Evol Microbiol. (2014) 64:2944–8. doi: 10.1099/ijs.0.057778-0
12. Véron M, Chatelain R. Taxonomic study of the genus Campylobacter Sebald and Véron and designation of the neotype strain for the type species, Campylobacter fetus (Smith and Taylor) Sebald and Véron. Int J Syst Bacteriol. (1973) 23:122–34. doi: 10.1099/00207713-23-2-122
13. Wagenaar JA, van Bergen MA, Blaser MJ, Tauxe RV, Newell DG, van Putten JP. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis. (2014) 58:1579–86. doi: 10.1093/cid/ciu085
18. Catena M, Callejas SS, Soto P, Aba MA, Echeverría HE, Monteavaro C, et al. Effects of experimental infection with Campylobacter fetus venerealis on early pregnancy in heifers. Rev Med Vet Investig. (2003) 5:37–44.
19. Jimenez DF, Perez AM, Carpenter TE, Martinez A. Factors associated with infection by Campylobacter fetus in beef herds in the Province of Buenos Aires, Argentina. Prev Vet Med. (2011) 101:157–62. doi: 10.1016/j.prevetmed.2011.05.014
20. Pellegrin AO, Lage AP, Sereno JRB, Ravaglia1 E, Costa MS, Leite RC. Bovine genital campylobacteriosis in Pantanal, Mato Grosso do Sul State, Brazil. Rev Elev Med Vet Pays Trop. (2002) 55:169–73. doi: 10.19182/remvt.9820
21. BonDurant RH. Venereal diseases of cattle: natural history, diagnosis, and the role of vaccines in their control. Vet Clin North Am Food Anim Pract. (2005) 21:383–408. doi: 10.1016/j.cvfa.2005.03.002
22. Campero CM, Anderson ML, Walker RL, Blanchard PC, Barbano L, Chiu P, et al. Immunohistochemical identification of Campylobacter fetus in natural cases of bovine and ovine abortions. J Vet Med. (2005) 52:138–41. doi: 10.1111/j.1439-0450.2005.00834.x
23. Morrell EL, Barbeito CG, Odeon CA, Gimeno EJ, Campero CM. Histopathological, immunohistochemical, lectinhistochemical and molecular findings in spontaneous bovine abortions by Campylobacter fetus. Reprod Domest Anim. (2011) 46:309–15. doi: 10.1111/j.1439-0531.2010.01668.x
24. Mshelia GD, Amin JD, Woldehiwet Z, Murray RD, Egwu GO. Epidemiology of bovine venereal campylobacteriosis: geographic distribution and recent advances in molecular diagnostic techniques. Reprod Domest Anim. (2010) 45:221–30. doi: 10.1111/j.1439-0531.2009.01546.x
26. IBGE. Censo Agropecuário (2017). Available online at: https://censos.ibge.gov.br/agro/2017/templates/censo_agro/resultadosagro/pdf/producao.pdf (Accessed August 05, 2018).
27. DIEA. Anuário estadístico agropecuário – MGAP (2017). Available online at: http://www.mgap.gub.uy/sites/default/files/diea-anuario2017web01a.pdf (Accessed August 05, 2018).
28. SENASA. Indicadores Bovinos. (2017). Available online at: http://www.senasa.gob.ar/cadena-animal/bovinos-y-bubalinos/informacion (Accessed August 05, 2018).
29. Molina LL, Angón E, García A, Moralejo RH, Caballero-Villalobos J, Perea J. Time series analysis of bovine venereal diseases in La Pampa, Argentina. PLoS ONE (2018) 13:e201739. doi: 10.1371/journal.pone.0201739
31. Figueiredo JF, Pellegrin AO, Fóscolo CB, Machado RP, Miranda KL, Lage AP. Evaluation of direct fluorescent antibody test for the diagnosis of bovine genital campylobacteriosis. Rev Latinoam Microbiol. (2002) 44:118–23.
34. Terzolo HR, Argento E, Catena MC, Cipolla AL, Martínez AH, Tejada G, et al. Procedimientos de Laboratorio Para el Diagnóstico de Campylobacteriosis y Trichomoniasis Genital Bovina. Comisión Científica Permanente de Enfermedades Venéreas de los Bovinos. INTA-Balcarce (1992). p.33.
35. McMillen L, Fordyce G, Doogan VJ, Lew AE. Comparison of culture and a novel 5′ Taq nuclease assay for direct detection of Campylobacter fetus subsp. venerealis in clinical specimens from cattle. J Clin Microbiol. (2006) 44:938–45. doi: 10.1128/JCM.44.3.938-945.2006
37. Hum S, Quinn K, Brunner J, On SL. Evaluation of a PCR assay for identification and differentiation of Campylobacter fetus subspecies. Aust Vet J. (1997) 75:827–31. doi: 10.1111/j.1751-0813.1997.tb15665.x
38. Abril C, Vilei EM, Brodard I, Burnens A, Frey J, Miserez R. Discovery of insertion element ISCfe1: a new tool for Campylobacter fetus subspecies differentiation. Clin Microbiol Infect. (2007) 13:993–1000. doi: 10.1111/j.1469-0691.2007.01787.x
39. Iraola G, Hernández M, Calleros L, Paolicchi F, Silveyra S, Velilla A, et al. Application of a multiplex PCR assay for Campylobacter fetus detection and subspecies differentiation in uncultured samples of aborted bovine fetuses. J Vet Sci. (2012) 13:371–6. doi: 10.4142/jvs.2012.13.4.371
40. Koya A, de Wet SC, Turner S, Cawdell-Smith J, Venus B, Greer RM, et al. Evaluation and histological examination of a Campylobacter fetus subsp. venerealis small animal infection model. Res Vet Sci. (2015) 99:1–9. doi: 10.1016/j.rvsc.2014.12.005
41. Marcellino RB, Morsella CG, Cano D, Paolicchi FA. Efficiency of bacteriological culture and the immunofluorescent assay to detect Campylobacter fetus in bovine genital fluids. Rev Argent Microbiol. (2015) 47:183–9. doi: 10.1016/j.ram.2015.03.008
42. Chaban B, García-Guerra A, Hendrick SH, Waldner CL, Hill JE. Isolation rates of Campylobacter fetus subsp. venerealis from bovine preputial samples via passive filtration on nonselective medium versus selective medium, with and without transport medium. Am J Vet Res. (2013) 74:1066–9. doi: 10.2460/ajvr.74.8.1066
44. Monke HJ, Love BC, Wittum TE, Monke DR, Byrum BA. Effect of transport enrichment medium, transport time, and growth medium on the detection of Campylobacter fetus subsp. venerealis. J Vet Diagn Invest. (2002) 14:35–9. doi: 10.1177/104063870201400107
48. Cipolla A, Cordeviola J, Terzolo H, Combessies G, Bardón J, Ramón N, et al. Campylobacter fetus diagnosis: direct immunofluorescence comparing chicken IgY and rabbit IgG conjugates. Altex (2001) 18:165–70.
49. Repiso MV, Gil A, Bañales P, D'anatro N, Fernandez L, Guarino H, et al. Prevalencia de las principales enfermedades infecciosas que afectan la reproducción en la ganadería de carne y caracterización de los establecimientos de cría del Uruguay. Veterinaria (2005) 40:5–28.
52. Devenish J, Brooks B, Perry K, Milnes D, Burke T, McCabe D, et al. Validation of a monoclonal antibody-based capture enzyme-linked immunosorbent assay for detection of Campylobacter fetus. Clin Diagn Lab Immunol. (2005) 12:1261–8. doi: 10.1128/CDLI.12.11.1261-1268.2005
53. Zhao H, Liu H, Du Y, Liu S, Ni H, Wang Y, et al. Development and evaluation of an indirect enzyme-linked immunosorbent assay for the detection of antibodies against Campylobacter fetus in cattle. Res Vet Sci. (2010) 88:446–51. doi: 10.1016/j.rvsc.2009.11.013
54. Brooks BW, Devenish J, Lutze-Wallace CL, Milnes D, Robertson RH, Berlie-Surujballi G. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay for detection of Campylobacter fetus in bovine preputial washing and vaginal mucus samples. Vet Microbiol. (2004) 103:77–84. doi: 10.1016/j.vetmic.2004.07.008
57. Guerra AG, Chaban B, Hill JE, Waldner CL, Hendrick SH. Clinical sensitivity and specificity of a real-time PCR assay for Campylobacter fetus subsp. venerealis in preputial samples from bulls. Am J Vet Res. (2014) 75:851–60. doi: 10.2460/ajvr.75.9.851
58. Groff A, Kirinus JK, Machado G, Costa MM, Vargas AP. Polymerase chain reaction for the diagnosis of bovine genital campylobacteriosis. Pesq Vet Bras. (2010) 30:1031–5. doi: 10.1590/S0100-736X2010001200005
59. Iraola G, Pérez R, Betancor L, Marandino A, Morsella C, Méndez A, et al. A novel real-time PCR assay for quantitative detection of Campylobacter fetus based on ribosomal sequences. BMC Vet Res. (2016) 12:286. doi: 10.1186/s12917-016-0913-3
60. Van der Graaf-van Bloois L, van Bergen MA, van der Wal FJ, de Boer AG, Duim B, Schmidt T, et al. Evaluation of molecular assays for identification Campylobacter fetus species and subspecies and development of a C. fetus specific real-time PCR assay. J Microbiol Methods (2013) 95:93–7. doi: 10.1016/j.mimet.2013.06.005
61. Iraola G, Pérez R, Naya H, Paolicchi F, Harris D, Lawley TD, et al. Complete genome sequence of Campylobacter fetus subsp. venerealis biovar intermedius, isolated from the prepuce of a bull. Genome Announc. (2013) 1:e00526–13. doi: 10.1128/genomeA.00526-13
62. Van der Graaf–van Bloois L, Miller WG, Yee E, Gorkiewicz G, Forbes KJ, Zomer AL, et al. Campylobacter fetus subspecies contain conserved type IV secretion systems on multiple genomic islands and plasmids. PLoS ONE (2016) 11:e152832. doi: 10.1371/journal.pone.0152832
63. Van der Graaf-van Bloois L, Miller WG, Yee E, Rijnsburger M, Wagenaar JA, Duim B. Inconsistency of phenotypic and genomic characteristics of Campylobacter fetus subspecies requires reevaluation of current diagnostics. J Clin Microbiol Infect. (2014) 52:4183–8. doi: 10.1128/JCM.01837-14
64. Van der Graaf–van Bloois L, Duim B, Miller WG, Forbes KJ, Wagenaar JA, Zomer A. Whole genome sequence analysis indicates recent diversification of mammal-associated Campylobacter fetus and implicates a genetic factor associated with H2S production. BMC Genom. (2016) 17:713. doi: 10.1186/s12864-016-3058-7
65. Wagenaar JA, van Bergen MA, Newell DG, Grogono-Thomas R, Duim B. Comparative study using amplified fragment length polymorphism fingerprinting, PCR genotyping, and phenotyping to differentiate Campylobacter fetus strains isolated from animals. J Clin Microbiol. (2001) 39:2283–6. doi: 10.1128/JCM.39.6.2283-2286.2001
66. Iraola G, Forster SC, Kumar N, Lehours P, Bekal S, García-Peña FJ, et al. Distinct Campylobacter fetus lineages adapted as livestock pathogens and human pathobionts in the intestinal microbiota. Nat Commun. (2017) 8:1367. doi: 10.1038/s41467-017-01449-9
67. Bove R, López F, Perera C, Carracelas B, Torres-Dini D, De Souza G, et al. Diagnosis of Campylobacter fetus venerealis in aborted bovine fetus. Veterinaria (2013) 49:20–8. doi: 10.13140/RG.2.2.19039.36005
69. Garcia EFS. Análisis Comparativo Entre Inseminación Artificial a Tiempo Fijo e Inseminación Artificial a Celo Detectado, Con Sus Variables Económicas y Reproductivas. Professional Practice Report. Caldas: Corporación Universitaria Lasallista, Facultad de Ciencias Administrativas y Agropecuarias. (2009).
70. INALE. Encuesta Lechera. (2014). Available online at: http://www.inale.org/innovaportal/file/4086/1/encuesta-lechera-2014–presentacion-resultados-preliminares-foro-a.pdf (Accessed June 24, 2018).
71. Akhtar S, Riemann HP, Thurmond MC, Franti CE. The association between antibody titres against Campylobacter fetus and reproductive efficiency in dairy cattle. Vet Res Commun. (1993) 17:183–91. doi: 10.1007/BF01839163
73. Stynen APR, Pellegrin AO, Fóscolo CB, Figueiredo JF, Canella FC, Leite RC, et al. Campilobacteriose genital bovina em rebanhos leiteiros com problemas reprodutivos da microrregião de Varginha-Minas Gerais. Arq Bras Med Vet Zoo. (2003) 55:766–9. doi: 10.1590/S0102-09352003000600015
74. Miranda KL. Prevalência da Campilobacteriose Genital Bovina em Touros de Corte em Alguns Estados Brasileiros em 2000. Dissertation/master's thesis. Belo Horizonte: Universidade Federal de Minas Gerais, UFMG (2005).
75. Rocha FSD, Jesus VLTD, Torres HM, Gomes MJ, Figueiredo MA, Nascimento ERD, et al. Campylobacter fetus and Tritrichomonas foetus investigation in prepucial mucous of bulls from Médio Paraíba/RJ region, Brazil. Cien Rural. (2009) 39:1586–9.
76. Alves TM, Stynen APR, Miranda KL, Lage AP. Bovine genital campylobacteriosis and bovine genital trichomonosis: epidemiology, diagnosis and control. Pesq Vet Bras. (2011) 31:336–44. doi: 10.1590/S0100-736X2011000400011
77. Ziech RE, Machado G, Kirinus JK, Libardoni F, Kessler JD, Pötter L, et al. Campylobacter fetus in cattle from Rio Grande do Sul state, Brazil. Cienc Rural. (2014) 44:141–6. doi: 10.1590/S0103-84782014000100023
78. Oliveira JMB, da Silva GM, Batista Filho AFB, de Melo Borges J, de Oliveira PRF, Brandespim DF, et al. Prevalence and risk factors associated with bovine genital campylobacteriosis and bovine trichomonosis in the state of Pernambuco, Brazil. Trop Anim Health Prod. (2015) 47:549–55. doi: 10.1007/s11250-015-0761-3
79. Filho RB, Malta KC, Lúcio EC, Nascimento GG, Dutra LC, Mota RA, et al. Prevalence of Campylobacter fetus subsp. venerealis in dairy cows from Brejo Paraibano, Brazil. Acta Sci Vet J. (2018) 46:7. doi: 10.22456/1679-9216.81811
80. Molina L, Perea J, Meglia G, Angón E, García A. Spatial and temporal epidemiology of bovine trichomoniasis and bovine genital campylobacteriosis in La Pampa province (Argentina). Prev Vet Med. (2013) 110:388–94. doi: 10.1016/j.prevetmed.2013.02.019
82. McFadden AM, Heuer C, Jackson R, West DM, Parkinson TJ. Investigation of bovine venereal campylobacteriosis in beef cow herds in New Zealand. N Z Vet J. (2005) 53:45–52. doi: 10.1080/00480169.2005.36468
83. Sanhueza JM, Heuer C, Jackson R, Hughes P, Anderson P, Kelly K, et al. Pregnancy rates of beef cattle are not affected by Campylobacter fetus subsp. venerealis real-time PCR-positive breeding sires in New Zealand. N Z Vet J. (2014) 62:237–43. doi: 10.1080/00480169.2014.898202
84. On SL, Harrington CS. Evaluation of numerical analysis of PFGE-DNA profiles for differentiating Campylobacter fetus subspecies by comparison with phenotypic, PCR and 16S rDNA sequencing methods. J Appl Microbiol. (2001) 90:285–93. doi: 10.1046/j.1365-2672.2001.01247.x
Keywords: Venereal Bovine Campylobacteriosis, infertility, abortions, Campylobacter fetus subsp. venerealis, diagnostic methods, South America
Citation: Silveira CS, Fraga M, Giannitti F, Macías-Rioseco M and Riet-Correa F (2018) Diagnosis of Bovine Genital Campylobacteriosis in South America. Front. Vet. Sci. 5:321. doi: 10.3389/fvets.2018.00321
Received: 23 August 2018; Accepted: 30 November 2018;
Published: 14 December 2018.
Edited by:Enrique Leopoldo Louge Uriarte, Instituto Nacional de Tecnología Agropecuaria (INTA), Argentina
Reviewed by:Horacio Raúl Terzolo, Retired, Buenos Aires, Argentina
Linda Van Der Graaf, Utrecht University, Netherlands
Copyright © 2018 Silveira, Fraga, Giannitti, Macías-Rioseco and Riet-Correa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Caroline da Silva Silveira, email@example.com